Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CASH FLOWS

v3.22.1
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (2,540) $ (2,641)
Adjustments to reconcile loss to net cash used in operating activities:    
Depreciation and amortization 52 55
Non-cash interest expense 0 1
Stock-based milestone payment 50 0
Stock-based compensation 253 248
Other 1 (5)
Changes in operating assets and liabilities:    
Receivables (106) 487
Inventory 0 110
Prepaid expenses and other assets (281) (241)
Accounts payable (350) (482)
Deferred grant revenue (84) 0
Other accrued liabilities 41 (157)
Net cash used in operating activities (2,964) (2,625)
Cash flows from financing activities:    
Net proceeds from equity offering 4,980 8,841
Net proceeds from the exercises of common stock warrants 1 0
Net cash provided by financing activities 4,981 8,841
Net increase in cash, cash equivalents and restricted cash 2,017 6,216
Cash, cash equivalents and restricted cash at beginning of period 6,332 5,413
Cash, cash equivalents and restricted cash at end of period $ 8,349 $ 11,629